Login
Shanghai Fosun Pharmaceutical OTC Market: SFOSF
Shanghai Fosun Pharmaceutical (Group) Co., Ltd., a healthcare company, engages in the research, development, manufacture, trade, and sale of pharmaceutical products
| Name | Shanghai Fosun Pharmaceutical |
| Ticker | SFOSF |
| Exchange | OTC Market |
| Sector | Health Care |
| Industry | Drug Manufacturers - Diversified |
| Price | 4.24 |
| 52W Low/High | 2.37 / 5.23 |
| Market cap | - |
| 1Y Total Return |
52.03%
Strong |
| 1Y Volatility |
60.36%
Average Risk |
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions
Shanghai Fosun Pharmaceutical (Group) Co., Ltd., a healthcare company, engages in the research, development, manufacture, trade, and sale of pharmaceutical products
Details
| Ticker | SFOSF |
| Name | Shanghai Fosun Pharmaceutical |
| ISIN | |
| CUSIP | |
| Exchange | OTC Market |
| Sector | Health Care |
| Industry | Drug Manufacturers - Diversified |
| Country | China |
| Currency | U.S. Dollar |
Share as of 9/25/20
| Close Price | 4.24 |
| 52W Low/High | 2.37 / 5.23 |
| Market cap | - |
| 1Y Total Return |
52.03%
Strong |
| 1Y Volatility |
60.36%
Average Risk |
| Beta | 1.08 |
| PE (trailing) | - |
| 12M Dividends | - |
| Last Dividend Date | 6/14/16 |
| Dividend Yield | - |
Fin. Strength
| Net Profit Margin | - |
| Cash from Op. / Cur. Liabilities | - |
| Diluted Earnings / Share | - |
| ROE | - |
| ROIC | - |
| Price / Revenue | - |
| Price / Book | - |
| Price / CF | - |
| Current Ratio | - |
| Cur.Liabilities / Tot.Liabilities | - |
| Financial Leverage | - |
No quarterly accounting data available at the moment
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available